Medpace Holdings Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +14.2% | +6.8% | +6.2% | +60.8% | +28.9% | +28.1% | +1.8% | +47.4% | +11.7% | +40.5% | +17.1% | |
| – | +2.1% | -16.4% | -20.0% | -16.5% | -40.2% | -15.8% | +8.1% | +5.8% | +17.8% | +11.1% | -7.1% | |
| – | +74.9% | -56.0% | -54.5% | +45.6% | +219.1% | -33.5% | +5.0% | +48.0% | -4.2% | +24.4% | +36.3% | |
| – | +630.7% | -43.8% | -116.7% | – | +169.1% | -56.1% | -253.7% | – | – | – | – | |
| – | – | +95.6% | +81.4% | +207.4% | -10.1% | +86.2% | +0.7% | +59.0% | +0.4% | +47.6% | -38.7% | |
| – | +21.6% | +109.4% | -9.2% | +30.4% | +11.8% | +75.0% | -9.8% | +30.4% | -0.6% | -0.3% | -14.2% | |
| – | -99.3% | +108.7% | -8.8% | +38.7% | +12.8% | +63.0% | +0.5% | +23.5% | -10.6% | -18.3% | +10.0% | |
| – | – | – | – | – | – | – | – | – | -48.5% | – | – | |
| – | -99.8% | -416.9% | +5,622.1% | – | +162.0% | -1,607.3% | -36.8% | +1,265.4% | -83.0% | +17.9% | +440.1% | |
| – | -124.6% | +94.0% | – | -357.5% | -44.2% | – | +0.0% | +0.0% | -200.0% | -100.0% | – | |
| – | -113.2% | -50.2% | +68.6% | +44.7% | -47.8% | +11.3% | -46.0% | +1,645.2% | -76.5% | -15.7% | +458.7% | |
| – | -168.0% | – | -155.5% | – | – | +34.2% | +25.8% | -335.9% | – | +95.2% | -140.7% | |
| – | +13.6% | -1.5% | +8.8% | +65.2% | +30.9% | +23.6% | +3.4% | +49.4% | +13.0% | +44.2% | +19.2% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.